Menu
Not yet recruiting NCT07435519

Effects of Klapp Method in Upper Cross Syndrome Patients

No phase Interventional Upper Cross Syndrome

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Klapp Method, Conventional treatment.
Who it may be relevant to
Registry conditions: Upper Cross Syndrome. Basic parameters: 18 years — 40 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Pakistan
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Effects of Klapp Method on Posture, Craniovertebral Angle and Disability in Upper Cross Syndrome Patients

Overview

This study was conducted to determine the effects of Klapp Method on posture, craniovertebral angle and disability in upper cross syndrome patients.

Interventions

  • Other Klapp Method
    Klapp Method: 3 sessions/week for 6 weeks Four-point walk followed by two-point walk \& back walk Breathing exercise from a kneeling position Simple bounce glide with simultaneous breathing Bunny hop Breathing exercise from a quadrupedal position: Greetings
  • Other Conventional treatment
    Conventional Physical Therapy Treatment : 3 sessions/week for 6 weeks Hot pack 10 min Stretching exercises for Levator scapulae 3 sets for 30 sec hold each. Upper trapezius 3 sets for 30 sec hold each. Pectoralis stretches: 3 sets for 30 sec hold each. Strengthening was given to : Upper, Middle and Lower Trapezius: 10 repetitions 3 sets. Serratus anterior: 10 repetitions and 3 sets. Infraspinatus: 10 repetitions 3 sets. Deep neck flexors: 30 seconds hold 3 sets.

Primary outcome measures

  • Craniovertebral Angle [Time frame: From enrollment to the end of treatment at 6 weeks]
  • Reedco Posture Score [Time frame: From enrollment to the end of treatment at 6 weeks]
  • Neck Disability Index [Time frame: From enrollment to the end of treatment at 6 weeks]

Eligibility criteria

Inclusion criteria

  • Both genders were included
  • Participants were between the ages of 18 to 40.
  • The craniovertebral angle was less than or equal to 50 degrees
  • The REEDCO Posture Assessment Scale of 59% or less.

Exclusion criteria

  • Patients that had a history of vascular syndrome, cervical spine infection, trauma, surgery, or cervical spine damage
  • Patients with inflammatory arthritis (such as rheumatoid arthritis or ankylosing spondylitis)

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Treatment

Study locations

Pakistan · 1 center
  • Fazle Omar Hospital — Rabwah

Publications

  • Yu L-J, Kim T-H. The effect of cervical stabilization exercises with thoracic spine extension exercises on forward head posture. International Journal of Human Movement and Sports Sciences. 2021;9(5):852-7.
  • Mocke RCF. A Comparison of Cervical and Thoracic Manipulation, Kinesio™ Abdominal Core Taping and the Combination of the Two in the Management of Upper Cross Syndrome: University of Johannesburg (South Africa); 2019.
  • Kang NY, Im SC, Kim K. Effects of a combination of scapular stabilization and thoracic extension exercises for office workers with forward head posture on the craniovertebral angle, respiration, pain, and disability: A randomized-controlled trial. Turk J Phys Med Rehabil. 2021 Sep 1;67(3):291-299. doi: 10.5606/tftrd.2021.6397. eCollection 2021 Sep. PMID 34870115
  • Dhage P, Anap D. Prevalence of an "Upper Crossed Syndrome in Physiotherapy College Students"-A Cross-Sectional Study. VIMS Health Science Journal. 2019;6(1):10-3.

Identifiers

NCT: NCT07435519 · REC/RCR&AHS/24/01101

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗